rs4730748

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001753.5(CAV1):​c.195+852A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.171 in 152,216 control chromosomes in the GnomAD database, including 2,436 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.17 ( 2436 hom., cov: 33)

Consequence

CAV1
NM_001753.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.270

Publications

7 publications found
Variant links:
Genes affected
CAV1 (HGNC:1527): (caveolin 1) The scaffolding protein encoded by this gene is the main component of the caveolae plasma membranes found in most cell types. The protein links integrin subunits to the tyrosine kinase FYN, an initiating step in coupling integrins to the Ras-ERK pathway and promoting cell cycle progression. The gene is a tumor suppressor gene candidate and a negative regulator of the Ras-p42/44 mitogen-activated kinase cascade. Caveolin 1 and caveolin 2 are located next to each other on chromosome 7 and express colocalizing proteins that form a stable hetero-oligomeric complex. Mutations in this gene have been associated with Berardinelli-Seip congenital lipodystrophy. Alternatively spliced transcripts encode alpha and beta isoforms of caveolin 1.[provided by RefSeq, Mar 2010]
CAV1 Gene-Disease associations (from GenCC):
  • pulmonary arterial hypertension
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • pulmonary hypertension, primary, 3
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • congenital generalized lipodystrophy type 3
    Inheritance: AD, AR Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, G2P
  • heritable pulmonary arterial hypertension
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Berardinelli-Seip congenital lipodystrophy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.199 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CAV1NM_001753.5 linkc.195+852A>G intron_variant Intron 2 of 2 ENST00000341049.7 NP_001744.2 Q03135-1Q2TNI1Q59E85
CAV1NM_001172895.1 linkc.102+852A>G intron_variant Intron 2 of 2 NP_001166366.1 A0A024R757Q2TNI1Q59E85
CAV1NM_001172896.2 linkc.102+852A>G intron_variant Intron 1 of 1 NP_001166367.1 A0A024R757Q2TNI1Q7Z4F3Q59E85
CAV1NM_001172897.2 linkc.102+852A>G intron_variant Intron 2 of 2 NP_001166368.1 A0A024R757Q2TNI1A9XTE5Q59E85

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CAV1ENST00000341049.7 linkc.195+852A>G intron_variant Intron 2 of 2 1 NM_001753.5 ENSP00000339191.2 Q03135-1

Frequencies

GnomAD3 genomes
AF:
0.171
AC:
26047
AN:
152098
Hom.:
2439
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.202
Gnomad AMI
AF:
0.242
Gnomad AMR
AF:
0.153
Gnomad ASJ
AF:
0.255
Gnomad EAS
AF:
0.0108
Gnomad SAS
AF:
0.177
Gnomad FIN
AF:
0.0694
Gnomad MID
AF:
0.239
Gnomad NFE
AF:
0.178
Gnomad OTH
AF:
0.185
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.171
AC:
26048
AN:
152216
Hom.:
2436
Cov.:
33
AF XY:
0.165
AC XY:
12308
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.202
AC:
8388
AN:
41498
American (AMR)
AF:
0.153
AC:
2334
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.255
AC:
884
AN:
3468
East Asian (EAS)
AF:
0.0108
AC:
56
AN:
5190
South Asian (SAS)
AF:
0.177
AC:
852
AN:
4820
European-Finnish (FIN)
AF:
0.0694
AC:
736
AN:
10612
Middle Eastern (MID)
AF:
0.233
AC:
68
AN:
292
European-Non Finnish (NFE)
AF:
0.178
AC:
12124
AN:
68012
Other (OTH)
AF:
0.183
AC:
386
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1106
2211
3317
4422
5528
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
282
564
846
1128
1410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0874
Hom.:
108
Bravo
AF:
0.179
Asia WGS
AF:
0.0860
AC:
301
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
6.5
DANN
Benign
0.69
PhyloP100
0.27
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4730748; hg19: chr7-116167595; API